Verition Fund Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,106
Closed -$180K 2238
2025
Q4
$180K Sell
18,106
-26,904
-60% -$257K ﹤0.01% 3199
2025
Q3
$403K Buy
45,010
+15,505
+53% +$144K ﹤0.01% 3141
2025
Q2
$278K Sell
29,505
-38,530
-57% -$340K ﹤0.01% 3235
2025
Q1
$737K Buy
+68,035
New +$685K ﹤0.01% 2341
2024
Q4
Sell
-15,272
Closed -$172K 3218
2024
Q3
$172K Sell
15,272
-40,514
-73% -$431K ﹤0.01% 2917
2024
Q2
$558K Buy
+55,786
New +$567K ﹤0.01% 1999
2022
Q2
Sell
-264,796
Closed -$4.25M 2299
2022
Q1
$4.25M Buy
264,796
+103,576
+64% +$1.86M 0.05% 474
2021
Q4
$3.94M Buy
161,220
+91,675
+132% +$2.15M 0.03% 475
2021
Q3
$1.62M Buy
+69,545
New +$1.68M 0.01% 747
2019
Q4
Sell
-117,800
Closed -$1.2M 1046
2019
Q3
$1.2M Buy
+117,800
New +$1.2M 0.03% 372

Other funds holding AHCO

Verition Fund Management's AHCO Position: Q1 2026 in Review

Verition Fund Management sold out of AdaptHealth (AHCO) in Q1 2026, closing a stake of 18,106 shares — an estimated $180K sold.

Verition Fund Management first reported a position in AHCO in Q3 2019 and held it in 10 quarters. The position peaked at $4.25M in Q1 2022. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Verition Fund Management reported no remaining AdaptHealth position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 18,106 AdaptHealth shares in Q1 2026, an estimated $180K.
  • Verition Fund Management first reported a position in AdaptHealth in Q3 2019 and held it in 10 quarters.
  • Verition Fund Management's AdaptHealth position peaked at $4.25M in Q1 2022.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.